(Q38059338)

28 August 2017

title

Mesenchymal stromal cells and regulatory T cells: the Yin and Yang of peripheral tolerance? (English)

1 reference

28 August 2017

Stephen P Burr

1

0 references

Francesco Dazzi

object named as

Francesco Dazzi

series ordinal

2

0 references

author name string

Oliver A Garden

series ordinal

3

1 reference

28 August 2017

publication date

13 November 2012

1 reference

Immunology & Cell Biology

28 August 2017

published in

1 reference

28 August 2017

volume

91

1 reference

28 August 2017

issue

1

1 reference

28 August 2017

page(s)

12-18

1 reference

Multilineage potential of adult human mesenchymal stem cells

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Human adipose tissue is a source of multipotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Mesenchymal stem cells reside in virtually all post-natal organs and tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Human mesenchymal stem cells modulate allogeneic immune cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

The immunomodulatory properties of mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Immune regulatory properties of multipotent mesenchymal stromal cells: Where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Macrophage polarization in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Toll-like receptors and their ligands control mesenchymal stem cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Suppressor Cells and Immunoregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Three T cell hybridomas do not contain detectable heavy chain variable gene transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Type 1 T regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

The regulatory T cell family: distinct subsets and their interrelations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

FOXP3+ regulatory T cells in the human immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

All creatures great and small: regulatory T cells in mice, humans, dogs and other domestic animal species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Regulatory T cells: how do they suppress immune responses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Contact-dependent induction of regulatory antigen-presenting cells by human mesenchymal stem cells is mediated via STAT3 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Functional alteration of the lymphoma stromal cell niche by the cytokine context: role of indoleamine-2,3 dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2,3-dioxygenase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Regulation of immune responses by prostaglandin E2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Prostaglandin E2 and the increase of intracellular cAMP inhibit the expression of interleukin 2 receptors in human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Prostaglandin E2-prostaglandin E receptor subtype 4 (EP4) signaling mediates UV irradiation-induced systemic immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Heme oxygenase-1: its therapeutic roles in inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Heme oxygenase-1 attenuates ovalbumin-induced airway inflammation by up-regulation of foxp3 T-regulatory cells, interleukin-10, and membrane-bound transforming growth factor- 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Prevention of allogeneic fetal rejection by tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Inhibition of T cell proliferation by macrophage tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

T cell apoptosis by tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Mesenchymal stem cell therapy for degenerative inflammatory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Moving to tolerance: clinical application of T regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Ex vivo-expanded CD4+CD25+ immunoregulatory T cells prevent graft-versus-host-disease by inhibiting activation/differentiation of pathogenic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Therapeutic potential of intravenously administered human mesenchymal stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Human FoxP3+ regulatory T cells in systemic autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Why should mesenchymal stem cells (MSCs) cure autoimmune diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Potential of mesenchymal stem cells for the therapy of autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Intraarterial administration of marrow stromal cells in a rat model of traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Sarcoma derived from cultured mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

Pretransplant Infusion of Mesenchymal Stem Cells Prolongs the Survival of a Semiallogeneic Heart Transplant through the Generation of Regulatory T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

21 January 2018

Mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

7 January 2021

Immunoregulatory effects of human dental pulp-derived stem cells on T cells: comparison of transwell co-culture and mixed lymphocyte reaction systems

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

7 January 2021

Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

7 January 2021

Toll-Like Receptors 3 and 4 Are Expressed by Human Bone Marrow-Derived Mesenchymal Stem Cells and Can Inhibit Their T-Cell Modulatory Activity by Impairing Notch Signaling

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

7 January 2021

CD4+CD25high regulatory cells in human peripheral blood

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

7 January 2021

Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

7 January 2021

Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

7 January 2021

Mechanism of TNF-α-induced migration and hepatocyte growth factor production in human mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

7 January 2021

The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

7 January 2021

Leukemia inhibitory factor: Role in human mesenchymal stem cells mediated immunosuppression

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

7 January 2021

Mesenchymal stem cell-mediated immature dendritic cells induce regulatory T cell-based immunosuppressive effect

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

7 January 2021

Allogeneic mesenchymal stem cells prevent allergic airway inflammation by inducing murine regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

7 January 2021

Mesenchymal cells recruit and regulate T regulatory cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

7 January 2021

Transforming growth factor-beta : biology and clinical relevance

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

7 January 2021

HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

7 January 2021

The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

7 January 2021

Immunomodulatory function of regulatory dendritic cells induced by mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

7 January 2021

Potential therapeutic applications of mesenchymal stromal cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

7 January 2021

HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

7 January 2021

Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

7 January 2021

Interleukin (IL)-10 induced by CD11b(+) cells and IL-10-activated regulatory T cells play a role in immune modulation of mesenchymal stem cells in rat islet allografts

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

7 January 2021

Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

7 January 2021

Reversal of serologic, immunologic, and histologic dysfunction in mice with systemic lupus erythematosus by long-term serial adipose tissue-derived mesenchymal stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

7 January 2021

Transplantation of CTLA4Ig gene-transduced adipose tissue-derived mesenchymal stem cells reduces inflammatory immune response and improves Th1/Th2 balance in experimental autoimmune thyroiditis

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

7 January 2021

Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

7 January 2021

Intracerebral transplantation of bone marrow with BDNF after MCAo in rat

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

7 January 2021

Intrapulmonary delivery of human umbilical cord mesenchymal stem cells attenuates acute lung injury by expanding CD4+CD25+ Forkhead Boxp3 (FOXP3)+ regulatory T cells and balancing anti- and pro-inflammatory factors

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

7 January 2021

Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

7 January 2021

Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

7 January 2021

The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study

1 reference

https://api.crossref.org/works/10.1038%2FICB.2012.60

7 January 2021

Identifiers

DOI

10.1038/ICB.2012.60

1 reference

28 August 2017

1 reference